Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20350)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition (GR) Value | Increased Fraction Dead |
|---|---|---|---|---|
| BT-20 | PB49673382 | 9.992797406 | 0.1062 | 0.04580 |
| BT-20 | SB1-F-22 | 9.992797406 | 1.0616 | -0.05972 |
| BT-20 | LDN57444 | 9.992797406 | -0.1024 | 0.31619 |
| BT-20 | P22077 | 9.992797406 | -0.1848 | 0.50178 |
| BT-20 | SB1-F-21 | 9.992797406 | -0.6752 | 0.57820 |
| BT-20 | HY-17541A | 9.992797406 | 0.5081 | 0.22583 |
| BT-20 | HBX 41108 | 9.992797406 | -0.4545 | 0.41070 |
| BT-20 | IU1 | 9.992797406 | 1.3315 | -0.09598 |
| BT-20 | ML-323 | 9.992797406 | 0.9554 | -0.04435 |
| BT-20 | Pevonedistat | 9.992797406 | -0.1336 | 0.25549 |
| BT-20 | Pimozide | 9.992797406 | 0.6110 | 0.02490 |
| BT-20 | 5-(4-fluorophenyl)-3-hydroxy-4-(5-methyl-2-furoyl)-1-(3-pyridinylmethyl)-1,5-dihydro-2H-pyrrol-2-one | 9.992797406 | 0.9478 | 0.02910 |
| BT-20 | 1247825-37-1 | 9.992797406 | 0.5818 | -0.00406 |
| BT-20 | HBX19818 | 9.992797406 | 1.0952 | -0.06178 |
| BT-20 | b-AP15 | 9.992797406 | -0.6673 | 0.55540 |
| BT-20 | Doxycycline | 9.992797406 | 1.1037 | -0.07504 |
| BT-20 | HY-17542 | 9.992797406 | 1.1087 | -0.02311 |
| BT-20 | HY-50737A | 9.992797406 | -0.4986 | 0.42351 |
| BT-20 | MI-2 | 9.992797406 | -0.7949 | 0.68738 |
| BT-20 | Mitoxantrone | 9.992797406 | -0.8289 | 0.72348 |
| BT-20 | HY-50736 | 9.992797406 | -0.5863 | 0.49618 |
| BT-20 | GW7647 | 9.992797406 | 1.1038 | -0.01682 |
| BT-20 | USP7-IN-1 | 9.992797406 | 1.0019 | 0.00357 |
| BT-20 | SJB3-019A | 9.992797406 | -0.5852 | 0.55773 |
| BT-20 | SJB2-043 | 9.992797406 | -0.5924 | 0.59176 |